Epsiode 50: Jonathan Rigby, Chairman and CEO, Sernova
Now on the Few & Far Between podcast: Did you know that one in ten people with Type 1 Diabetes (TD1) die from hypoglycemia? Today's guest, who has TD1, explains how he turned his passion for helping others into innovative treatments for diabetes and other chronic diseases. Host Chris O'Brien welcomes Jonathan Rigby, Chairman and CEO at Sernova, to the podcast. Listen in as we spotlight Jonathan's 30-year industry journey, the development of implantable bio-hybrid organs, and how to plan for your first 30 days in a new biotech role. Tune in today!
Episode 50 of the Few & Far Between: How Biotech Gets Built podcast, hosted by Chris O'Brien, titled "Epsiode 50: Jonathan Rigby, Chairman and CEO, Sernova" was published on March 18, 2025 and runs 52 minutes.
March 18, 2025 ·52m · Few & Far Between: How Biotech Gets Built
Summary
Now on the Few & Far Between podcast: Did you know that one in ten people with Type 1 Diabetes (TD1) die from hypoglycemia? Today's guest, who has TD1, explains how he turned his passion for helping others into innovative treatments for diabetes and other chronic diseases. Host Chris O'Brien welcomes Jonathan Rigby, Chairman and CEO at Sernova, to the podcast. Listen in as we spotlight Jonathan's 30-year industry journey, the development of implantable bio-hybrid organs, and how to plan for your first 30 days in a new biotech role. Tune in today!
Episode Description
Now on the Few & Far Between podcast:
Did you know that one in ten people with Type 1 Diabetes (TD1) die from hypoglycemia? Today's guest, who has TD1, explains how he turned his passion for helping others into innovative treatments for diabetes and other chronic diseases.
Host Chris O'Brien welcomes Jonathan Rigby, Chairman and CEO at Sernova, to the podcast. Listen in as we spotlight Jonathan's 30-year industry journey, the development of implantable bio-hybrid organs, and how to plan for your first 30 days in a new biotech role.
Tune in today!
Similar Episodes
Apr 13, 2026 ·17m
Apr 6, 2026 ·11m
Mar 30, 2026 ·17m
Mar 23, 2026
Mar 16, 2026